The contractor shall provide staffing services for select projects and activities in support of the talent development learning center (tdlc) at the center for veterinary medicine.
Ended Awarded Last action
- Contract number
- 75F40123F19283
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $86,932
Award facts
- Contract value 100% obligated
- $86,932.08 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$219 | |
| Original award | $87,151 |
About this award
The Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) call contract to Brillient Corporation for staffing services supporting select projects and activities at the Talent Development Learning Center (TDLC) within the Center for Veterinary Medicine. This labor-hour contract, awarded on May 30, 2023, carries a ceiling value of approximately $87K and is scheduled for ultimate completion by November 20, 2025. The contract is being closed out through this modification, which de-obligates remaining funds. Brillient Corporation, a minority-owned full spectrum digital transformation company, will provide professional and technical staffing support from the performance location in Silver Spring, Maryland. The contract does not utilize a set-aside designation and is part of the FDA's broader reliance on the General Services Administration's Multiple Award Schedule (MAS) for professional services procurement.
Brillient Corporation is an established federal contractor with extensive experience across the Department of Health and Human Services and related agencies. The company maintains significant contract vehicles including a $55.3 million BPA with the Department of the Treasury's Internal Revenue Service and a $58.5 million indefinite delivery contract with the National Institutes of Health, demonstrating substantial capacity in program management, technical services, and administrative support. This TDLC staffing engagement represents a smaller-scale tactical deployment of Brillient's professional services capabilities in support of the FDA's veterinary medicine training and development initiatives.
Quick answers
Who was awarded contract 75F40123F19283?
75F40123F19283 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on May 30, 2023.
How much is contract 75F40123F19283 worth?
The government has obligated $86,932 on 75F40123F19283.
Is contract 75F40123F19283 an order under another contract?
Yes. 75F40123F19283 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40123F19283 competed?
The extent of competition for 75F40123F19283 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award